High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up

University Medical Center Groningen885 enrolled

Overview

Collection of follow-up data from the original trial patient cohort.

Collection of follow-up data from the original trial patient cohort by means of structured patient file abstraction, a questionnaire to the general practitioner, and registry consultations.

Study Type

OBSERVATIONAL

Enrollment

885

Conditions

Breast Cancer Female

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Enrolment in the original trial. Exclusion Criteria: * None.

Locations (10)

Academic Medical Center

Amsterdam, Netherlands

The Netherlands Cancer Institute

Amsterdam, Netherlands

VU University Medical Center

Amsterdam, Netherlands

Medisch Spectrum Twente

Enschede, Netherlands

Outcomes

Primary Outcomes

Overall survival

Overall survival according to the definition and analysis plan of the original study

Time frame: 2 years

Relapse-free survival

Relapse-free survival according to the definition and analysis plan of the original study

Time frame: 2 years

Secondary Outcomes

Incidence of cardiovascular events

Time frame: 2 years

Incidence of malignancies

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.